Latest News

Jun 20, 2019
Lytix Biopharma announces two recent publications on LTX-401, a second generation molecule developed for treatment of visceral tumors
Jun 20, 2019
Intratumoral treatment with LTX-315 causes regression of Desmoid Tumor- A case history
Jun 13, 2019
Nobel Laureate Dr James Allison and Oncologist Dr Padmanee Sharma joins Lytix as Company Strategic Advisors and in SAB
May 14, 2019
Lytix Biopharma is invited as a speaker at a Medicon Valley Alliance meeting